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Hematology, University Hospital and University of Zurich, Zurich, Switzerland
Continuous production of blood cells unfolds within a complex three-dimensional tissue 
scaffold established by highly organized stromal cell networks of mesenchymal, neural, 
and vascular origin inside bone marrow (BM) cavities. Collectively, stromal cells have 
been shown to serve two principal roles; first as primary participants of bone remodel-
ing and metabolism and second as master regulators of different stages of blood cell 
development and production. Indeed, ample evidence demonstrates that stromal cells 
can sense and integrate systemic signals to shape hematopoietic responses and that 
these regulatory mechanisms are subverted in multiple pathologic conditions. Microbial 
infections are stressors that elicit potent inflammatory reactions and induce substantial 
alterations of hematopoietic output. Whether the cellular components of the BM stromal 
microenvironment are targeted by infections and participate in infection-induced hema-
topoiesis has not been investigated in sufficient detail to date. In this manuscript, we 
provide a succinct updated overview of the different cell populations that are currently 
known to form BM stroma. We discuss experimental evidence demonstrating that differ-
ent stromal components are actively damaged or functionally altered by pathogens and/
or ensuing inflammatory signals and review how these effects are known to contribute to 
the hematologic manifestations observed during infections.
Keywords: microenvironment, bone marrow, hematopoiesis, microbial infections, stromal cells, niche
iNTRODUCTiON
Bone marrow (BM) tissues are home to the continuous, lifelong, and high-throughput production of 
almost all blood cell lineages for the entire lifetime of adult individuals (1). Thus, the BM is arguably 
the most dynamic and self-renewing organ in the human body. Extremely rare, marrow-residing, 
hematopoietic stem cells (HSCs) maintain high rates of mature blood cell generation by continuously 
differentiating along the different branches of the hematopoietic hierarchy. While doing so, HSCs 
as well as multipotent and lineage-committed progenitor subsets self-renew, thereby preventing the 
rapid exhaustion of the system (2–4). Highly sophisticated regulatory mechanisms that operate at 
different levels of hematopoietic development are required to promote an adequate balance between 
self-renewal and differentiation in order to ensure that continuous cellular production qualitatively 
and quantitatively matches the demands of organism (5).
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Hematopoiesis unfolds within a defined tissue infrastructure 
provided by BM stromal cells of non-hematopoietic origin, 
including a variety of endothelial, mesenchymal, and neural cells. 
Collectively, the BM stromal framework has emerged as a master 
regulator of hematopoiesis as well as bone metabolism (6, 7). For 
instance, signals emanating from a variety of stromal components 
have proven indispensable for the homeostasis of HSC popula-
tions. The regulatory crosstalk between stromal cells and HSCs 
is hypothesized to occur in so-called HSC niches, which have 
been studied in greatest detail for their relevance and possible 
implications in stem cell biology and regenerative medicine 
(8–10). Nonetheless, the functions of endothelial, mesenchymal, 
and neural cells are not restricted to HSC regulation but extend 
throughout the entire BM hematopoietic development and 
include cellular trafficking, lineage-specific differentiation, tissue 
structural support, and metabolic regulation (6, 11).
Pathogenic infections significantly disrupt the described 
homeostatic state of the BM by driving profound alterations in 
the patterns of lineage production, highly increasing the need 
and rate of hematopoietic output, and thereby imposing a sig-
nificant strain in the regenerative capacity of the BM (12). As an 
example, most bacterial infections have been shown to provoke 
a rapid switch to the so-called state of emergency hematopoiesis, 
which leads to a shift toward preferential production and BM 
egress of myeloid cells (i.e., emergency myelopoiesis) (13, 14). 
Such conserved responses most likely have evolved to promptly 
compensate for the massive consumption of immune cells, 
mostly granulocytes or monocytes that are recruited to infection 
sites (12). In contrast, certain viral agents are well known to lead 
to BM suppression and pancytopenia (15). Thus, BM hematopoi-
etic responses are highly pathogen-specific, will vary depending 
on microbial tropism and host immune responses, and need to 
be studied in an individualized fashion. Hematopoietic perturba-
tions are generally the consequence of the combined effects of (i) 
direct pathogenic targeting of relevant hematopoietic and non-
hematopoietic cell types, (ii) the action of microbe-associated 
molecular patterns (MAMPs) through activation of pattern 
recognition receptors PRRs in a variety of cell subsets, and (iii) 
the inflammatory cytokines released as part of immune responses 
destined to control infectious challenges (16).
Numerous recent experimental studies have focused in dis-
secting how hematopoietic cells in the BM directly respond to 
microbial infections. HSPCs themselves, given their prominent 
position at the apex of the hierarchy, represent a unique target 
for the modulation of hematopoiesis in a global, rapid, and 
versatile fashion during stress (5, 16–18). Indeed, it was recently 
demonstrated that HSCs are primary responders to infections as 
they are directly targeted by MAMPs and multiple inflammatory 
cytokines, such as IFNα, IFNγ, IL-1, interleukin-6 (IL-6), or 
TNFα, which distinctively affect their cycling properties, differ-
entiation, repopulating activity, and migration patters (5, 16, 17, 
19). Notably, the instructive effects of host and pathogen-derived 
mediators are not limited to HSCs. Different multipotent and 
lineage-restricted progenitor subsets have been shown to undergo 
direct infection by certain intracellular pathogens and/or respond 
to MAMPs and cytokines, which can eventually trigger deviations 
or blockage of their normal differentiation potential and lineage 
output (20–22).
Altogether, it seems clear that the different ways in which 
hematopoietic elements sense and respond to pathogenic stimuli 
and ensuing inflammation will critically shape the global BM 
hematopoietic response during the different phases of a micro-
bial infection. Yet, given its well-documented essential role in 
the orchestration of steady-state hematopoiesis, the potential 
contribution of the BM stromal microenvironment to infection-
mediated hematopoiesis should not be neglected (18). Whether 
and how BM-resident stromal cells are targeted by infections still 
remains poorly defined. Furthermore, to what extent structural 
and functional changes in BM stroma underlie the observed 
effects of pathogens in hematopoietic function needs to be 
further investigated. Notably, experimental evidence gathered in 
a variety of tissues but specifically in lymphoid organs strongly 
indicates that in general, stromal cells are not passive bystanders 
but rather play a very active role in remodeling of organ structure 
and physiology during stress responses (23, 24). In this article, we 
provide a brief account of the different stromal subsets forming 
the BM microenvironment and their regulatory control of hemat-
opoiesis as delineated by recent studies in the murine system and 
summarize what is known on the pathophysiological responses 
of these cells to infections. Finally, we revise relevant knowledge 
derived from clinical practice, which points to a prominent role 
of BM stromal cells in the hematological manifestations observed 
in human infectious diseases.
CeLLULAR COMPONeNTS OF BM 
STROMA
The presence of a rich non-hematopoietic cellular fraction in 
the BM had been long appreciated and its likely role as a funda-
mental orchestrator of hematopoiesis anticipated for many years 
(25). However, its constituents were until recently only vaguely 
grouped under the term “stroma,” their heterogeneity and func-
tions remaining underappreciated (26). Driven by a number of 
technical and methodological advances, remarkable progress 
has now been achieved in the understanding of the composition, 
phenotypic characterization, developmental origin, anatomy, and 
crucial functions of BM stromal components. First, an assortment 
of reporter mouse models in which mesenchymal, vascular, and 
neural BM populations are genetically targeted and/or fluores-
cently illuminated in a specific manner have been generated (6, 
27). In parallel, protocols that include the enzymatic digestion of 
BM tissues and permit the extraction of large stromal cells now 
enable their identification by flow cytometry and prospective 
isolation via cell sorting, for a detailed molecular and functional 
analysis (28–30). Finally, improved in  situ or in  vivo imaging 
approaches that allow the simultaneous visualization of diverse 
BM components have been developed and are now being widely 
employed to understand their three-dimensional microanatomi-
cal organization (31–34). Collectively, these new tools are proving 
invaluable for the mapping of the heterogeneity contained in BM 
stroma, as well as for the understanding of the ways in which 
these multiple cell types orchestrate hematopoiesis.
FiGURe 1 | Cellular components of the stromal compartment of the bone marrow (BM): schematic overview of BM stromal cellular constituents in a 
mouse femur. Endothelial cells of arterial (AECs), transitional (type H), and sinusoidal [sinusoidal ECs (SECs)] subtypes form the vascular system of the BM. Densely 
packed AECs form arteries and arterioles, which connect to type H transitional vessels, that give rise to sinusoids made up by large SECs (upper panel, zoomed-in 
image). AECs, type H, and SECs have different morphological, phenotypic, and molecular features and have been shown to play specific roles in the regulation of 
hematopoiesis and osteogenesis. The neural component of BM stroma is formed by rare non-myelinating Schwann cells and adrenergic neurons. The mesenchymal 
compartment includes progenitor subpopulations such as fibroblastic reticular stromal cells, also termed CXCL12-abundant reticular cells (CARc), and Nes-GFPhi 
cells (upper panel, zoomed-in image). Mature mesenchymal cells are composed of bone-lining osteoblasts (Obs) and adipocytes.
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BM endothelial Cells (BMeCs)
The BM is perfused by an extremely dense microvascular tree 
comprised by a variety of BM endothelial cell subtypes, which 
assemble into distinct vessels that largely differ in morphology, 
phenotype, and function (30, 31, 35–37). Following the arche-
typical structure of vascular trees, oxygenated blood enters the 
BM through arterial vessels, which branch into thinner arterioles. 
Arterial circulation transitions into large venous structures 
through a set of transitional vessels (also termed type H) in the 
proximity of endosteal surfaces (31, 32, 35). In the BM, venous 
thin-walled vessels construct a dense and highly interconnected 
network designated as sinusoidal (38) (Figure 1). Arterial vessels 
display low permeability, shielding the surrounding extravascular 
space from access to plasma-derived factors (36). Due to their 
anatomical localization at the interface between BM and bone 
surfaces, type H vessels critically influence bone remodeling (35). 
Sinusoids in turn are highly permeable and therefore serve as the 
main trafficking routes for cells in and out of BM tissues (39, 40).
Different subtypes of BMECs can be isolated and studied 
based on their specific phenotypic signature (29, 30, 36), the 
distinct expression of adhesion molecules, and the production 
of trophic hematopoietic factors, which has proven of relevance 
for their different biological functions (11, 41). As an example, 
sinusoidal ECs (SECs) among other angiocrine factors produce 
high levels of stem cell factor (SCF), CXCL12, and E-selectin, 
through which they critically participate in the maintenance 
and quiescence of HSPCs in perisinusoidal niches (42–45). 
Based on this molecular profile and the spatial interactions they 
establish, SECs have been further postulated as key regulators in 
different stages of hematopoietic cell development, such as the 
maintenance of mature megakaryocytes or the differentiation of 
immature B cells (7, 40, 46–48). An essential additional task of 
BMECs is the regulation of tissue regeneration and restoration of 
HSC homeostasis after extreme injury with ionizing radiation or 
chemotherapeutic agents, to which the fragile BM hematopoietic 
compartment is highly sensitive (29).
BM Mesenchymal Cells
The mesenchymal compartment of the BM is not only engaged 
in hematopoietic regulation but also it contains a stem cell-
based hierarchy required for bone development, homeostatic 
remodeling, and repair (49). The developmental roadmap by 
which multipotent mesenchymal stem cells (MSCs) give rise to 
chondrocytes, osteoblasts and adipocytes in situ within the BM 
is much less clearly defined than the hematopoietic hierarchy. 
Recent reports have provided new insight into the mesenchymal 
compartment through the use of novel genetically engineered 
mouse models to target and trace mesenchymal populations. 
These studies are gradually uncovering a rather complex scenario 
(50–52). The nuances of the system have been elegantly and thor-
oughly reviewed elsewhere and largely exceed the scope of this 
manuscript (6). For the purpose of this review, it is important to 
note that a general confusion has historically pervaded the field 
regarding the use of the term MSCs. Besides referring to the true 
bona fide skeletal stem cell and mesenchymal progenitors present 
in native BM tissues, the name MSC was indistinctively employed 
to designate the product of the in vitro clonogenic expansion of 
the adherent cell fraction isolated from different organs, which 
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featured adipogenic, osteogenic, and chondrogenic potential 
in vitro (49, 53). The latter have been extensively characterized for 
their immunomodulatory properties in vitro and upon transplan-
tation, which may be therapeutically exploited in the context of 
severe infectious and inflammatory challenge (54). However, in 
this manuscript, we will exclusively refer to those studies, which 
have addressed the effects of infections in MSCs or mesenchymal 
progenitor cells that reside in and can be prospectively isolated 
from BM tissues.
Mesenchymal stem cells are proposed to give rise in  situ to 
a fibroblastic reticular cell network that densely populates BM 
and holds strong morphological and structural resemblance to 
stromal lattices found in other lymphoid organs, such as lymph 
nodes and spleen (23) (Figure 1). BM reticular cells, identified 
based on their expression of leptin receptor (Lepr), comprise 
the majority of progenitor cells that generate osteoblasts and 
adipocytes in steady state, as well as chondrocytes and reticular 
stroma in the context of bone repair (55–57). Fibroblastic stromal 
cells abundantly express factors that are absolutely indispensable 
for the hematopoietic function of the BM (55). For instance, they 
are the most prominent source of CXCL12 [thus designated as 
CXCL12-abundant reticular (CAR) cells] and SCF, through 
which they promote retention and maintenance of HSPCs in 
the BM (42–44). Beyond their regulation of early hematopoietic 
progenitors, at least a subset of Lepr+ reticular cells additionally 
secretes interleukin-7 (IL-7) and therefore contributes to differ-
ent stages of lymphoid lineage development (47, 58, 59). Other 
less well-characterized subpopulations of mesenchymal origin 
have been described. These include periarteriolar cells defined 
in the NestinGFP mouse model by the highest expression of the 
transgene, and a subset of perivascular cells found mostly in tra-
becular bone regions, which express NG2 and PDGFRβ (33, 60).
Mature osteoblasts line the inner surfaces of bone and 
constitute one of the direct mature derivatives of mesenchymal 
reticular stromal cells (56, 61). Although their primary function 
is the production and secretion of mineralized matrix needed for 
continuous remodeling of bone surfaces, osteoblasts have been 
extensively studied for their regulatory crosstalk with the hemat-
opoietic system. Initial studies pointed to a role of osteoblasts in 
providing a supportive HSC niche (62, 63). Nonetheless, recent 
evidence suggests that signals derived from the mature osteoblas-
tic or endosteal niche are rather required for the maintenance of 
lymphoid progenitors and balanced T and B cell lymphopoiesis 
(43, 64–67). One of the alternative cellular fates of mesenchymal 
Lepr+ cells is differentiation into adipocytes (55, 56). Marrow 
adipogenesis is a highly complex phenomenon, the functional 
implications of which are only superficially understood. In 
general terms, adipocytes are regarded as negative regulators 
of hematopoiesis, which emerge mostly in the context of pro-
nounced marrow injury and aging [(68); reviewed in Ref. (69)].
BM Neural Cells
Cells of neural origin include glial GFAP+ non-myelinating 
Schwann cells (NMSCs) and adrenergic neurons, which are 
scarcely distributed throughout the BM interstitium (70, 71). 
NMSCs have been shown to participate in the maintenance of 
HSC quiescence through production of activated transforming 
growth factor-β (70). Adrenergic signals relayed by sympathetic 
nerves most likely play multiple unexplored and complex roles 
in BM hematopoietic function but have been studied for their 
control of the constant cellular trafficking in and out of the BM 
(71, 72). During homeostasis, HSCs are rhythmically released 
from BM into peripheral circulation in a pattern that is governed 
by the adrenergic-mediated control of CXCL12 expression levels 
(71). Likewise, continuous cell recruitment to the BM, which 
is dependent on cellular adhesive interactions with the micro-
vasculature, oscillates following circadian cycles established by 
adrenergic signaling (72). Neural-derived signals have been 
additionally demonstrated to critically contribute to the complete 
and rapid structural regeneration of BM post-injury (73).
iNFeCTiON-iNDUCeD ALTeRATiONS iN 
BM STROMAL MiCROeNviRONMeNT
Although the basic observation that balanced hematopoiesis and 
consequently BM dynamics are highly reactive to infectious chal-
lenges was recognized longtime ago, relatively few experimental 
studies have addressed how specific pathogenic infections and 
ensuing inflammatory responses directly impact the composi-
tion, structure, and function of BM stroma (Table 1). On the basis 
of recent investigations in animal models of infections, we here 
propose three main types of mechanisms by which pathogens 
may lead to major perturbations of the microenvironmental 
control of BM function (Figure 2).
First, direct stimulation by microbial products and/or inflam-
matory cytokines has been reported to lead to profound changes 
in the transcriptional signature and signaling repertoire of compo-
nents of the stromal microenvironment, which ultimately result in 
the diversion of hematopoietic output toward infection-induced 
patterns. Second, via the action of cytokines, microbial-derived 
peptides, or even through direct infection of specific stromal cell 
populations, pathogens can trigger detrimental effects in stromal 
cell integrity, leading to apoptosis or induction of aberrant dif-
ferentiation programs. The resulting lesions in stromal networks 
will inevitably impact the normal regulatory features of the BM 
microenvironment. Finally, infections may drive defective stro-
mal cell physiology by indirect mechanisms. For instance, mas-
sive consumption and depletion of inflammatory hematopoietic 
cells from the BM result in a severely altered cellular landscape, 
which may indirectly lead to deranged stromal cell maintenance/
survival. Obviously, single pathogenic infections likely hinder 
BM stromal function at multiple levels and through the complex 
combination of several of these described modes of interference, 
which are non-mutually exclusive. Experimental data supporting 
the infection-mediated activation of the referred mechanisms of 
alteration of BM stromal cell physiology are discussed in detail in 
the following sections.
infection-induced Remodeling of BM 
Stromal Cell Function
Akin to mature hematopoietic cells and HSPCs, certain BM stro-
mal subsets have been shown to express specific receptors that 
render them susceptible to the direct action of microbial agents 
TABLe 1 | Reported effects of mouse and human pathogens in bone marrow (BM) stromal cells.
Type of 
pathogen
Pathogen/microbial 
product
BM stromal subset 
targeted
Hematopoietic response Mechanism Reference
Parasite Toxoplasma gondii Mesenchymal stromal cells Enhanced myeloid output, block in 
erythropoiesis
Stromal-derived interleukin-6 (IL-6) secretion (74)
Bacteria Polymicrobial, sepsis 
model
Osteoblasts Ablation of common lymphoid 
progenitors, block in T and B 
lymphopoiesis
G-CSF-mediated ablation of osteoblasts and 
decrease in interleukin-7
(75)
Escherichia coli and 
lipopolysaccharide 
administration
BM endothelial cells (BMECs) 
and ECs from other organs
Emergency granulopoiesis TLR4-mediated and G-CSF-dependent (76, 77)
Mobilization of HSPCs to blood and 
spleen
TLR and NOD-induced G-CSF secretion in 
non-hematopoietic cell
(76)
Listeria 
monocytogenes
Mesenchymal 
osteoprogenitors/CXCL12-
abundant reticular (CAR) 
cells
Monocyte mobilization Mesenchymal stromal cell expression of 
CCL2
(78)
Mycobacterium 
tuberculosis (human)
Mesenchymal stromal cells Not defined Direct intracellular infection of mesenchymal 
stromal cells
(79)
c-di-GMP (bacterial 
second messenger)
Osteoprogenitors, CAR cells 
and BMECs
Decrease in numbers and dysfunction 
of BM HSCs and extramedullary 
hematopoiesis
Decrease in BMECs and BM mesenchymal 
stromal cell populations
(80)
virus Lymphocytic 
choriomeningitis virus
Mesenchymal stromal cells Biased differentiation of HSPCs toward 
myeloid lineage
IL-6 secretion by mesenchymal stromal cells 
triggered by IFNγ from CD8 T cells
(81)
MCMV In vitro cultures of 
mesenchymal stromal cells
Loss of HSPC supportive capacity—
potential cause of aplasia
Direct infection and decrease of 
hematopoietic supportive factor expression
(82, 83)
Human 
immunodeficiency 
virus (human)
In vitro cultures of BMECs 
and mesenchymal stromal 
cells
Loss of HSPC supportive capacity—
potential cause of pancytopenia
Direct infection, decrease of hematopoietic 
supportive factor expression
(84–86)
Cytomegalovirus 
(human)
In vitro cultures of 
mesenchymal stromal cells
Loss of HSPC supportive capacity—
potential contribution to BM failure 
posttransplantation
Direct infection, decrease of hematopoietic 
supportive factor expression
(87–89)
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and inflammatory cytokines, as well as the molecular machinery 
needed to couple these signals into a defined intracellular activa-
tion program that alters their regulatory function. For instance, 
endothelial cells isolated from multiple organs, including the BM, 
consistently express TLR4 and its intracellular signaling protein, 
myeloid differentiation gene 88 (Myd88) (93). The integrity of 
this pathway in vascular cells is crucial for emergency granu-
lopoiesis in the context of infections with Gram-negative bac-
teria. Using cell subset-specific deletion of Myd88 expression in 
mice, Boettcher et al. demonstrated that upon lipopolysaccharide 
(LPS)-mediated TLR4 stimulation, endothelial cells upregulate 
the principal granulopoietic cytokine, G-CSF to boost myeloid 
differentiation of hematopoietic progenitors (77). Although the 
specific contribution of BMECs with respect to those in vascular 
compartments of other organs was not determined, upregulation 
of G-CSF expression was most prominent in BMECs, suggesting 
the existence of at least a partial contribution of the local vascular 
compartment to overproduction of myeloid cells (90).
Albeit through different mechanisms, certain viral infec-
tions have been reported to similarly induce a skewing toward 
myeloid differentiation already at the level of HSPCs, through 
modulation of stromal-derived signals. Lymphocytic choriomen-
ingitis virus (LCMV) is a natural murine pathogen, which has 
been widely employed in the discovery of general features of 
antiviral immune responses (94). During the early phases of 
acute LCMV infections, a myeloid HSPC fate is transiently 
enforced in order to accelerate production of myelomonocytic 
innate immune cells. The reactive shift in HSPC fate was shown 
to depend on the upregulation of IL-6 secretion by CAR cells, 
which in turn was triggered by IFNγ production by activated 
BM CD8 cytotoxic T cells (81). Of importance, previous stud-
ies had shown that acute LCMV infections induced transient 
BM aplasia, suppression of HSC function, and a pancytopenic 
state (95, 96). These effects were mediated, at least partially by 
the direct action of IFNα/β and IFNγ on hematopoietic cells. 
However, the possible contribution of stromal alterations in the 
context of LCMV infections had not been addressed in these 
studies. Notably, increased IL-6 production of CAR cells has 
also been observed upon infection with the rodent parasite 
Toxoplasma gondii (74). In this setting, induction of IL-6 not 
only augmented myeloid differentiation but also additionally 
elicited an anemic condition by stalling early stages of eryth-
roid development in infected mice. Nevertheless, unlike LCMV 
infections, both IL-6 upregulation and anemia in this case were 
found to be independent of IFNγ, suggesting that multiple 
distinct mechanisms can operate to trigger local IL-6 secretion 
during different pathogenic inflammatory conditions (74).
Beyond altering the cytokine and growth factor milieu of 
the BM to instruct hematopoietic differentiation, infections or 
immunepathological reactions bring about (i) major changes 
in pro-migratory and retention cues provided by mesenchy-
mal stromal cells and (ii) a breach in the barrier function and 
cell trafficking control exerted by BM vascular structures. 
Both effects critically contribute to the rapid mobilization of 
FiGURe 2 | Mechanisms of pathogen-induced alterations in bone 
marrow (BM) stromal cells. (A) Endothelial and mesenchymal BM cells 
sense microbial-derived products or inflammatory cytokines. 
Lipopolysaccharide (LPS) stimulates endothelial cell [sinusoidal EC (SEC)] 
secretion of G-CSF, leading to emergency granulopoiesis and HSPC 
mobilization (76, 90). Secretion of IFNγ by CD8 cells during antiviral 
responses activates interleukin-6 (IL-6) production by CXCL12-abundant 
reticular (CAR) cells, which in turn induces biased differentiation of HSPCs 
toward myeloid lineages (81). Bacterial LPS has also been shown to stimulate 
CCL2 production by CAR cell, leading to monocyte extravasation from BM 
into circulation (78). (B) Excess levels of pro-inflammatory cytokines or active 
targeting by pathogens can induce stromal cell death leading to aberrant BM 
microenvironmental regulation of hematopoiesis. During polibacterial sepsis, 
osteoblast (Ob) numbers are decreased through the activation of apoptotic 
programs mediated by G-CSF (75). Administration of the bacterial second 
messenger c-di-GMP leads to reduced numbers of CXCL12-abundant 
reticular cells (CARc) and SECs (80). (C) Myeloid cells, mainly macrophages 
and aged neutrophils, modulate CXCL12 production by CAR cells, leading to 
the cyclic release of hematopoietic stem cells (HSCs) from BM to circulation 
(91, 92). Given that infections and inflammatory challenges massively change 
the numbers and frequencies of myeloid cells in BM, it is conceivable that 
such changes promote alterations in CAR cell functionality.
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mature and immature hematopoietic cells from the BM to the 
periphery, which is a hallmark and a stereotypic host response 
to multiple pathogenic challenges (97–99). On the one hand, 
rapid deployment of mature cells, mostly of the myelomonocytic 
pool, increases the availability of circulating cells, which can be 
recruited to infected tissues for pathogen clearance (13, 14). In 
addition, mobilization of immature progenitors and HSCs leads 
to the transient establishment of extramedullary hematopoiesis 
(EMH) in other organs, mostly the spleen. EMH is a sign of 
dysfunction of the BM microenvironment, which is not only 
observed during infections but also in multiple stress-related 
conditions, and it is hypothesized to temporarily preserve early 
hematopoietic progenitors in a facultative supportive microen-
vironment (100, 101). However, a minor fraction of circulating 
HSPCs is found to traffic to peripheral tissues and differentiate 
in situ into immune cells, thereby contributing to local infectious 
control (102).
The mechanisms driving massive cellular exit from BM dur-
ing infections are incompletely understood and will likely differ 
between the hematopoietic cell types mobilized and the type of 
pathogen. A general mechanism involves the interference of the 
CXCR4/CXCL12 axis, which is the major molecular pathway 
involved in BM retention described thus far. Expression and 
protein levels of CXCL12 in the BM are substantially reduced 
during certain bacterial infections, thus leading to release of 
HSPCs to peripheral circulation and lodging in spleen (76, 
103). Given that CAR cells are the main source of CXCL12 in 
the BM and prominently express other adhesion molecules 
such as VCAM-1, it is highly likely that cell mobilization at 
least partially results from the erosion of the pro-retention 
function of this cell type. Supporting this notion, a recent study 
demonstrated that HSPC mobilization during Escherichia coli 
infection was mediated by increased G-CSF production, which 
has been shown to specifically reduce CXCL12 expression in 
CAR cells (104). Interestingly, in this infectious model, G-CSF 
secretion is triggered by the combined activation of TLR4 and 
NOD receptors in an undefined non-hematopoietic cell type, 
most likely endothelial as suggested by previous studies (76, 
90). The attenuation of CXCL12-mediated retention signals 
does not only induce release of HSPCs from BM but also is 
hypothesized to contribute to rapid neutrophil egress during 
infections (105).
Besides this general mechanism, CAR cells additionally 
participate in BM cellular egress during infections in an active 
manner. Upon sensing of low levels of circulating LPS, BM 
perisinusoidal CAR cells upregulate expression of the pro-
migratory chemokine CCL2, which is essential for emigration of 
CCR2+ inflammatory monocytes across sinusoidal vessels into 
systemic circulation (78). The resulting increase in frequencies 
of circulating monocytes was shown to be critical for efficient 
clearance of pathogen clearance of Listeria monocytogenes 
infections.
infection-induced Damage to BM Stromal 
Cells
As observed for vascular and mesenchymal scaffolds in other 
lymphoid organs, pathogenic insults have been recently reported 
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to selectively impact BM stromal cell survival (23, 106). Resulting 
cellular lesions can lead to imbalance in stromal composition 
and/or structural defects, which in turn have sizeable and distinct 
effects in the hematopoietic system. Deleterious actions in stroma 
may be induced by sharp increases in local pro-inflammatory 
cytokine levels. Using a murine model of sepsis induced by cecal 
ligation and puncture, Terashima and colleagues recently proved 
that mature, bone-lining osteoblast populations are strongly 
decreased during polymicrobial infection (75). Partial depletion 
of the osteoblast pool resulted in a paucity of IL-7 production 
in the BM microenvironment and consequently, a major loss of 
common lymphoid progenitors, which compromised T and B 
lymphopoiesis. In this case, the observed reduction in osteoblast 
numbers was independent of TLR signaling, but again at least 
partially mediated by abnormally high G-SCF levels (75). These 
observations are well in line with the previously reported nega-
tive effect of exogenously administered G-CSF on osteoblastic 
populations (104). Remarkably, infection-induced depletion of 
osteoblasts and its consequences could be mitigated through acti-
vation of osteoblastic proliferation using parathyroid hormone 
(75). Although, it should be cautioned that an IL-7-expressing 
niche in human BM tissues has not been described to date, these 
findings are highly relevant as they may contribute to mechanisti-
cally explain and potentially prevent the persistent lymphopenic 
state that frequently leads to fatal secondary infections in septic 
patients. Notably, an independent study using a similar model 
of polymicrobial systemic infection further revealed conspicu-
ous signs of mesenchymal stromal cell damage in BM, which 
included a partial loss of structural integrity and the abundant 
emergence of adipocytes, indicative of the induction of aberrant 
differentiation programs in mesenchymal progenitor cells (107).
Bone marrow stromal cell subsets are also sensitive to the 
direct action of pathogenic virulence factors. For instance, 
administration of the bacterial second messenger bis-(3′–5′)-
cyclic dimeric guanosine (c-di-GMP) was recently shown to 
strongly reduce endothelial and CAR cell numbers in BM and 
compromise their ability to produce relevant HSPC niche factors, 
such as CXCL12 or kit-L (80). Consequently, HSPCs were mobi-
lized to the periphery, subsequently homing and proliferating in 
the spleen. c-di-GMP is known to trigger immune responses in 
a variety of cell types through the activation of the endogenous 
endoplasmic receptor stimulator of IFN genes (STING). Of 
importance, multiple cell types, including HSPCs and immune 
cells, express STING receptors. Hence, it cannot be ruled out that 
the damaging effect of c-di-GMP is at least to some extent medi-
ated indirectly, through activation of inflammatory cascades in 
other cell types.
Finally, evidence suggests that stromal populations can be 
directly infected by certain intracellular pathogens this poten-
tially leading to stromal cell death or dysfunction. Such is the 
case for viral agents, such as cytomegalovirus (CMV) and human 
immunodeficiency virus (HIV), which infect BM mesenchymal 
stromal cells and suppress their hematopoietic supportive capac-
ity in  vitro (see discussion below). In addition, it was recently 
reported that Mycobacterium tuberculosis displays specific 
tropism for the mesenchymal compartment of the BM, which 
acts as a reservoir for pathogen persistence and dissemination 
(79). However, from this study, it was unclear whether long-term 
latency in mesenchymal stromal cells had an impact in the bone 
forming or hematopoietic regulatory functions of MSCs.
Deregulation of Hematopoietic Cell 
Crosstalk with BM Stroma
While much work has focused in understanding how stromal cells 
influence the BM hematopoietic compartment, regulatory cross-
talk is most likely bidirectional and significantly less is known 
on the potential mechanisms by which hematopoietic cells may 
shape their microenvironment. Understanding such reciprocal 
modulation may become especially crucial during inflammatory 
stress situations in which the hematopoietic content of the BM 
undergoes drastic qualitative and quantitative alterations due to 
massive egress and entry of immune cell subsets, as well as biased 
HSPC lineage differentiation.
In steady state, myeloid cells have been reported to regulate 
CAR cell functionality at least via two different mechanisms. BM 
macrophages provide cues that ensure production of sufficient 
levels of CXCL12 by CAR cells both in vitro and in vivo, through a 
yet unknown mechanism (91). Depletion of CD169+ macrophage 
populations consequently results in abnormally low CXCL12 lev-
els and defective HSPC retention in BM. Macrophages have been 
further reported to play a completely unanticipated role in the 
indirect modulation of HSPC mobilization via a complex mecha-
nism involving CAR cells, as well as neutrophils. Macrophages 
are responsible of the clearance of aged, dysfunctional circulating 
neutrophils, which takes place among other organs in the BM 
(108). For their elimination, as neutrophils age they are recruited 
to the BM parenchyma in waves, which follow circadian fluctua-
tions and are thus synchronized by sympathetic nervous signals. 
The time window of maximal BM neutrophil entry within the 
regular light–dark cycles was observed to precede that of most 
active HSPC egress to circulation. Mechanistically, it was dem-
onstrated that BM macrophages engulfing aged neutrophils are 
activated through cholesterol receptors and relay a signal to CAR 
cells that temporarily downmodulates their CXCL12 expres-
sion (92). As a consequence, waves of HSPC mobilization toward 
the blood are rhythmically generated. Collectively, the findings 
described above strongly suggest that the changing dynamics of 
BM-resident myelomonocytic cell subsets in the context of infec-
tions could potentially affect BM stromal function, a hypothesis 
that deserves further in-depth studies. On the basis of the evidence 
discussed above, it seems clear that the BM microenvironment 
and each of its individual components represent highly suscepti-
ble substrates for the indirect action of pathogenic stimuli in the 
hematopoietic system.
CLiNiCAL-BASeD eviDeNCe OF BM 
STROMAL DYSFUNCTiON iN HUMAN 
iNFeCTiONS
Beyond the experimental studies in animal models here 
described, relevant information on the effects of pathogenic 
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challenges on the BM microenvironment has been derived 
from the extensive clinical characterization of hematological 
syndromes induced by infectious diseases in humans. BM mani-
festations are associated to multiple pathogenic infections, espe-
cially by certain viruses, which frequently lead to pancytopenia, 
aplastic anemia, and/or severe failure of BM function (109, 110). 
In some cases, the pathophysiological mechanisms underlying 
BM symptoms and the nature of the cells affected have been 
identified. For instance, parvovirus B19 is well known to induce 
anemia through preferential infection of erythroid progenitors 
to halt their maturation (20, 109). In many infections, histologi-
cal examination of BM biopsies reveals substantial microarchi-
tectural damage, thus suggesting some sort of perturbation of 
stromal integrity (111). Yet, distinct stromal deficiencies in the 
context of infections have only been investigated in some detail 
for few human viral agents.
Infection with human CMV, a member of the Herpesvirus 
family, remains to this day one of the major complications 
following allogeneic BM transplants, eventually causing hemat-
opoietic and graft failure, as well as fatal multi-organ disease 
(112). CMV infections, which are prevalent and remain latent in 
the majority of the population, are reactivated in immunosup-
pressed individuals. Evidence from human and murine studies 
strongly suggests that a major contributing cause lies in the direct 
damage that CMV inflicts to BM stroma. In vitro, CMV infects 
human BM mesenchymal stromal cultures compromising their 
hematopoietic supportive capacity (87–89). Likewise, murine 
CMV induces transient BM aplasia and has been shown to also 
infect BM mesenchymal cultures altering their capacity to secrete 
multiple growth factors and cytokines relevant for their control 
of hematopoiesis (82, 83). Similar in vitro observations have been 
made for other human and mouse viruses, such as hepatitis B virus 
and LCMV (113). Of interest, LCMV infections also impaired 
hematopoietic repopulation post-BM transplantation in mouse 
models (114). However, given that these viruses not only target 
stromal cells but also infect BM-mononuclear cells and directly 
suppress colony-forming capacity in vitro, it is conceivable that 
perturbations of both non-hematopoietic and hematopoietic 
cells will synergize to account for the observed failure in marrow 
engraftment (87, 94, 115).
A variety of hematopoietic disorders, including cytopenias 
and prominent BM morphological alterations, have also been 
extensively reported in HIV patients (116, 117). The etiology 
of hematopoietic BM syndromes in HIV-infected individuals 
remains hard to precise, given that besides the viral agent, 
multiple factors can contribute to the pathophysiology of BM 
impairment. These include drug-induced cytotoxicity, chronic 
inflammatory disease, the presence of additional opportunistic 
infections, and the development of disease-related neoplasms. 
Nonetheless, experimental evidence points to a direct effect of 
HIV infections in the BM stromal microenvironment. Early 
studies after the emergence of AIDS demonstrated that HIV 
infection was not only restricted to lymphocytic cells but also 
affected mesenchymal and endothelial cells in the BM (84–86). 
Upon infection, in  vitro cultured mesenchymal stromal cells 
display suppressed hematopoietic supportive capacity and 
have been shown to become senescent and modify their 
differentiation potential when exposed to the viral proteins Tat 
and Nef (118).
CONCLUDiNG ReMARKS
Our understanding of the composition and organization of the 
cellular landscape of the BM has dramatically enhanced in the 
last decade. As progress has been attained, stromal cells that form 
the BM microenvironment have taken center stage, revealing as a 
compartment of unanticipated heterogeneity, versatility, dynamic 
nature, and pleiotropic functions. The phenotype, localization, 
and function of different stromal elements in the control of 
hematopoietic function continue to be explored. Nonetheless, 
with the knowledge generated thus far, new, highly pertinent 
questions arise on the role of stroma in stress situations in which 
an enhanced cellular supply is required or in which BM function 
is compromised. Indeed, the potential contribution of the BM 
microenvironment to pathological hematopoiesis has become 
increasingly apparent and the focus of multiple studies. Although 
much is still to be learnt, it seems clear that BM stromal cells 
respond in distinct ways to different microbial infections and the 
inflammatory responses launched by host organisms. On the one 
hand, stromal cell activation is likely an essential facet of the pre-
programmed and coordinated biological response to dynamically 
adjust hematopoietic output to new demands. However, it also 
seems evident that acute and chronic inflammatory processes as 
well as direct microbial infection can have dire effects in stromal 
functionality that contribute to subsequent pathological hemat-
opoiesis and possibly immune suppression. Hence, there is a clear 
need for refined knowledge on (i) the specific cellular subsets 
targeted during different pathogenic processes, (ii) the molecular 
cascades affected, (iii) the modes in which stromal changes may 
dictate reactive hematopoiesis, and (iv) the relative contribution 
of these changes to the global response in BM hematopoiesis 
compared to direct effects on hematopoietic cells. As hinted by 
existing studies (75), such information should directly translate 
into novel pharmacological strategies to prevent BM stromal cell 
damage and therefore therapeutically ameliorate hematologic 
symptoms caused by infections.
Nonetheless, the implications of such basic insights will 
certainly reach beyond the prevention of infection-associated 
hematopoietic alterations. It will be essential to understand 
whether ongoing low-grade persistent infections or sequels left in 
BM stroma by prior infectious events contribute to precipitate, if 
not directly drive, the development of more severe hematopoietic 
diseases. For instance, inflammation-driven functional remod-
eling of BM stromal components is critical for the development 
and progression of certain BM neoplasms (119). Hence, it can 
be speculated that preexisting inflammatory lesions in stromal 
cells could be relevant predisposing factors for hematologic 
neoplasms by providing a fertile ground for growth of malignant 
cells. Moreover, it will be crucial to determine whether and how 
infection-related perturbations may hinder the natural regenera-
tive capacity of the BM stromal infrastructure, which is needed for 
the recovery of tissue integrity and function after myeloablative 
treatments widely employed nowadays. The fact that CMV infec-
tions still represent severe problems in BM transplant patients 
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clearly exemplifies the need for more in-depth biological studies 
to uncover the pathophysiology of these processes. Finally, given 
the well-established link between inflammation and aging, it is 
tempting to speculate that the accumulation throughout an entire 
lifetime of unresolved injuries in BM stroma may cause, at least 
partially, the aged-associated defects in BM microenvironmental 
regulation of hematopoiesis (120). We are convinced that the 
use of currently available experimental models and technologies 
will help to provide clear answers to these and other questions 
on the relevance of stromal-derived signals for pathological 
hematopoiesis.
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